Reducing Harm from Respiratory Depression Associated with Opioids

The presentation will provide an overview of the latest published 2017 toolkit from the California Hospital Quality Institute (HQI), designed to assist healthcare organizations in their efforts to reduce harm from respiratory depression associated with opioid administration.

Presented by Kevin M. McQueen, MHA, RRT, CPPS, CM

This Live AARC webcast is approved for 1.0 CRCE

Seminar Objectives
  • Identify the seven most common challenges/contributing factors associated with opioid-induced respiratory depression/arrests
  • Describe the respiratory monitoring care process steps
  • Describe how organizations can determine the best monitoring technology options for their organization
Seminar Information
Date Presented:
March 27, 2018 2:00 PM Eastern
Expiration Date:
March 27, 2018 11:55 PM
Length:
1 hour
Registration Fee:
$15.00
Reducing Harm from Respiratory Depression Associated with Opioids
Individual topic purchase: Selected
American Association for Respiratory Care
Continuing Respiratory Care Education: 1.00